BlackRock’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.3M Buy
11,457,979
+590,888
+5% +$4.81M ﹤0.01% 2074
2025
Q1
$85.3M Buy
10,867,091
+1,172,829
+12% +$9.21M ﹤0.01% 2080
2024
Q4
$144M Sell
9,694,262
-38,137
-0.4% -$568K ﹤0.01% 1844
2024
Q3
$149M Sell
9,732,399
-30,714
-0.3% -$470K ﹤0.01% 1821
2024
Q2
$149M Sell
9,763,113
-137,228
-1% -$2.09M ﹤0.01% 1786
2024
Q1
$187M Sell
9,900,341
-134,829
-1% -$2.55M ﹤0.01% 1674
2023
Q4
$192M Buy
10,035,170
+416,343
+4% +$7.95M ﹤0.01% 1657
2023
Q3
$173M Buy
9,618,827
+146,790
+2% +$2.63M 0.01% 1620
2023
Q2
$192M Sell
9,472,037
-666,983
-7% -$13.5M 0.01% 1601
2023
Q1
$185M Buy
10,139,020
+749,972
+8% +$13.7M 0.01% 1587
2022
Q4
$194M Buy
9,389,048
+460,820
+5% +$9.53M 0.01% 1544
2022
Q3
$234M Buy
8,928,228
+805,534
+10% +$21.1M 0.01% 1348
2022
Q2
$206M Buy
8,122,694
+3,983,168
+96% +$101M 0.01% 1502
2022
Q1
$131M Buy
4,139,526
+9,597
+0.2% +$303K ﹤0.01% 1939
2021
Q4
$167M Sell
4,129,929
-73,031
-2% -$2.96M ﹤0.01% 1865
2021
Q3
$147M Buy
4,202,960
+164,232
+4% +$5.73M ﹤0.01% 1931
2021
Q2
$111M Buy
4,038,728
+645,082
+19% +$17.7M ﹤0.01% 2167
2021
Q1
$95.3M Buy
3,393,646
+138,555
+4% +$3.89M ﹤0.01% 2203
2020
Q4
$84.5M Buy
3,255,091
+125,809
+4% +$3.27M ﹤0.01% 2146
2020
Q3
$53.6M Buy
3,129,282
+490,190
+19% +$8.4M ﹤0.01% 2213
2020
Q2
$65.3M Sell
2,639,092
-141,256
-5% -$3.49M ﹤0.01% 2082
2020
Q1
$38.6M Sell
2,780,348
-228,414
-8% -$3.17M ﹤0.01% 2198
2019
Q4
$30.4M Buy
3,008,762
+106,774
+4% +$1.08M ﹤0.01% 2619
2019
Q3
$26.4M Buy
2,901,988
+665,855
+30% +$6.06M ﹤0.01% 2636
2019
Q2
$17.8M Buy
2,236,133
+404,432
+22% +$3.22M ﹤0.01% 2883
2019
Q1
$22.9M Buy
1,831,701
+109,807
+6% +$1.37M ﹤0.01% 2666
2018
Q4
$18.5M Buy
1,721,894
+1,286,470
+295% +$13.9M ﹤0.01% 2746
2018
Q3
$6.07M Buy
435,424
+100,154
+30% +$1.4M ﹤0.01% 3406
2018
Q2
$4.1M Buy
335,270
+315,621
+1,606% +$3.86M ﹤0.01% 3506
2018
Q1
$303K Buy
+19,649
New +$303K ﹤0.01% 4078